Leukocytapheresis (LCAP) in the Management of Chronic Active Ulcerative Colitis—Results of a Randomized Pilot Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Leukocytapheresis (LCAP) in the Management of Chronic Active Ulcerative Colitis—Results of a Randomized Pilot Trial

Published:2007-04-05 Issue:9 Volume:52 Page:2044-2053
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Emmrich Jörg,Petermann Sebastian,Nowak Dietrich,Beutner Ingolf,Brock Peter,Klingel Reinhard,Mausfeld-Lafdhiya Patrick,Liebe Stefan,Ramlow Wolfgang

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-006-9696-x.pdf

Reference29 articles.

1. Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nature Rev Immunol 3:521–533

2. Sandborn WJ (1998) Azathioprine: state of the art in inflammatory bowel disease. Scand J Gastroenterol 225:92–99

3. Hanauer SB (2004) Medical therapy for ulcerative colitis 2004. Gastroenterol 126:1582–1592

4. Baumgart DC, Wiedenmann B, Dignass AU (2003) Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 17:1273–1281

5. Loftus CG, Loftus EV, Sandborn WJ (2003) Cyclosporin for refractory ulcerative colitis. Gut 52:172–173

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apheresis in Inflammatory Bowel Disease: Current Evidence;Crohn’s Disease Recent Advances;2021-10-20

2. Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta-analysis;BMJ Open;2021-05

3. Safety and efficacy of leukocytapheresis in elderly patients with ulcerative colitis: The impact in steroid-free elderly patients;Journal of Gastroenterology and Hepatology;2018-03-04

4. Treatment of inflammatory bowel disease by leukocytapheresis;Transfusion and Apheresis Science;2017-06

5. Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis;Internal Medicine;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3